Daniel W. Sherbenou
- Hematology top 2%
- Genetics top 2%
- Molecular Biology
- Oncology top 10%
- Rheumatology top 5%
- Co-authors
- Brian DrukerMichael W. DeiningerThomas G.P. BummPeter A. ForsbergTomer M. MarkSu YangMichael C. HeinrichChristopher R. Behrens
- Topics
- Multiple Myeloma Research and Treatments (26 papers)Protein Degradation and Inhibitors (13 papers)Chronic Lymphocytic Leukemia Research (11 papers)
- Cited by
- HematologyGeneticsRheumatology
- Journals
- Journal of Clinical InvestigationJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesAustriaGermany
In The Last Decade
Daniel W. Sherbenou
37 papers receiving 896 citations
Peers
Comparison fields: 5 of 58
- Hematology 587
- Genetics 381
- Molecular Biology 349
- Oncology 289
- Rheumatology 199
Countries citing papers authored by Daniel W. Sherbenou
This map shows the geographic impact of Daniel W. Sherbenou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel W. Sherbenou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel W. Sherbenou more than expected).
Fields of papers citing papers by Daniel W. Sherbenou
This network shows the impact of papers produced by Daniel W. Sherbenou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel W. Sherbenou. The network helps show where Daniel W. Sherbenou may publish in the future.
Co-authorship network of co-authors of Daniel W. Sherbenou
This figure shows the co-authorship network connecting the top 25 collaborators of Daniel W. Sherbenou. A scholar is included among the top collaborators of Daniel W. Sherbenou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel W. Sherbenou. Daniel W. Sherbenou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 9 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 6 | |
| 6 | 16 | |
| 7 | 7 | |
| 8 | 2 | |
| 9 | 0 | |
| 10 | 18 | |
| 11 | 9 | |
| 12 | 6 | |
| 13 | 56 | |
| 14 | 9 | |
| 15 | 83 | |
| 16 | 31 | |
| 17 | 85 | |
| 18 | 61 | |
| 19 | 151 | |
| 20 | 4 |
About Daniel W. Sherbenou
Daniel W. Sherbenou is a scholar working on Hematology, Genetics and Rheumatology, having authored 40 papers that have together received 911 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (26 papers), Protein Degradation and Inhibitors (13 papers) and Chronic Lymphocytic Leukemia Research (11 papers). The work is most often cited by research in Hematology (587 citations), Genetics (381 citations) and Rheumatology (199 citations). Daniel W. Sherbenou has collaborated with scholars based in United States, Austria and Germany. Frequent co-authors include Brian Druker, Michael W. Deininger, Thomas G.P. Bumm, Peter A. Forsberg, Tomer M. Mark, Su Yang, Michael C. Heinrich, Christopher R. Behrens, Bin Liu and Richard T. Silver. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.